September 21, 2004
Bookmark and Share

WADA Executive Committee approves the 2005 Prohibited List

Montreal, September 21, 2004 – The World Anti-Doping Agency (WADA) announced today that its Executive Committee approved the Prohibited List of Substances and Methods for 2005. The new List will be published prior to October 1, 2004, and will go into effect January 1, 2005.

Some changes will be made from the current List in 2005. For example, the topical application of glucocorticosteroids will no longer require an abbreviated therapeutic use exemption. Beta-2 agonists, often used in the treatment of asthma, will now be prohibited both in and out of competition. Due to the findings of a WADA-sponsored research project, Finasteride, a product used for prostate problems in men and also for hair loss, will be added to the Prohibited List as a masking agent. Finally, intravenous infusion for non-medical purposes will now be explicitly banned.

The Executive Committee based its decisions regarding the List on the recommendations of WADA’s List Committee and Health-Medical and Research Committee, which met in September to discuss the 2005 List. Since 2004, WADA has been tasked with issuing the List on an annual basis, a responsibility previously held by the International Olympic Committee (IOC). A substance or method is added to the List if it meets two of three criteria: it is performance enhancing, poses a danger to athletes’ health, and its use is against the spirit of sport.

“Refining the List is an important part of WADA’s responsibilities under the World Anti-Doping Code,” said Richard W. Pound, WADA’s president. “The changes we have made this year reflect our expanding scientific knowledge and our ability to better identify performance enhancing substances and methods.”


The Executive Committee also discussed the 2005 draft budget. The proposed budget calls for an increase of US$ 1.47 million to $21,705,000. This would represent the first such increase in 2 years. The budget will be approved by WADA’s Foundation Board at its November meeting.

WADA’s budget and government contributions in 2004 were also discussed. WADA has received 80 percent of its budget to date this year from governments and the IOC. The United States has committed to pay $1.45 million soon after the start of its fiscal year October 1, bringing the total contributions this year to more than 90 percent.

In addition, WADA has also this year collected a further $3.9 million from governments and the IOC for funds due in 2002 and 2003.

“We are very pleased that governments now seem to have their budgetary processes in place for meeting their financial commitments to WADA,” Pound said. “We have collected more money this year from our stakeholders than ever before. This reflects the commitment of governments and the sports movement to WADA and allows the Agency to carry on the necessary work and scientific research to continue to fight doping.”


More than US$ 3 million was committed by the Committee for 17 research projects for 2004. Fifty-seven proposed research projects were considered for funding by WADA this year.

Since 2001, WADA has committed more than $11 million to research on four priority research areas previously defined by the Executive Committee. The Committee, in 2003, defined research as one of WADA’s top priorities.

Election of Vice-Chairman

The Committee recommended a process for the election of a vice-chairman for the WADA Foundation Board. As per WADA’s constitution, Board members are eligible to become vice-chairman. The Committee agreed that nominations for this position will be put forward by mid-November and the Board will vote for a candidate at its November 21 meeting.

The elected vice-chairman will serve for a period of one year.

Regional Offices

A decision was made to permanently fund WADA’s regional office in Cape Town, South Africa. The office, which opened in November 2003, has been funded to date by the South African government. WADA will assume full responsibility for the office beginning November 1, 2004.

“Our regional offices serve an important purpose in allowing us to liaise with our stakeholders in every part of the world,” said David Howman, WADA’s director general. “I am pleased the Committee agreed to assume responsibility for the South African office and we extend our gratitude to the Government of South Africa for their assistance in getting our operations off the ground in that country.”

The Committee also discussed the establishment of a regional office in Latin America. The Committee voted to explore the possibility of establishing such an office in this region. WADA will now work to determine the most appropriate location for establishing this office.